yabo体育yabo体育首页

GenScript Biotech Global Forum

Cell & Gene Therapy and the Booming China Market

Grand Ballroom, Grand Hyatt San Francisco
Tuesday, January 14, 2020

GenScript Biotech Global Forum

About GBGF

Cell & gene therapy have gained prominence in the biotechnology industry in recent years, creating hope for a new era of cancer treatment. The promise of these new treatments has attracted global attention and is offering vast opportunities for innovation and capital investment. To examine these opportunities, GenScript is pleased to launch its inaugural GenScript Biotech Global Forum, which will take place on Tuesday, Jan. 14 at the Grand Hyatt San Francisco Hotel during the 2020 JP Morgan Healthcare Conference.

Exploring the theme of "Cell & Gene Therapy and the Booming China Market,",GenScript aims to build a bridge between the cell and gene therapy research and development field and the capital community. The forum will bring together leading academic and industry professionals, experienced investors and international regulatory authorities to discuss topics such as how to forge global collaborations and how to accelerate regulatory approvals to bring life-saving products to patients more quickly. Join us in San Francisco this year at what promises to be a unique opportunity to share insights and collaborate on the global advancement of cell and gene therapy.

Event Highlight

Agenda

14:00 - 14:05

Welcome

Sally Wang, co-founder, Executive Director and President, GenScript Biotech

14:05 - 14:15

Opening Remarks

Frank Zhang, Ph.D., Founder, Chairman and CEO, GenScript Biotech

14:15 - 14:55

Keynote Speech

Scott Gottlieb, M.D., Former FDA Commissioner

14:55 - 15:35

Panel Discussion
Global Progress in Cell Therapy and Opportunities in China

Moderator: Usman Azam, M.D., CEO, Tmunity Therapeutics
Panelist:
Peter Emtage, Ph.D., Global Head of Cell Therapy Research, Kite Pharma, a Gilead Company
Phil Vanek, Ph.D., GM of Cell and Gene Therapy Strategy and Business Development, GE Healthcare Life Sciences
Frank Fan, M.D., Ph.D. ,CSO, Legend Biotech
Laurence Cooper, M.D., Ph.D. ,CEO , Ziopharm Oncology
Dan Wang, M.D., Head, Johnson & Johnson Innovation Asia Pacific
Zonghai Li, M.D., Ph.D.,CEO&CSO, CARsgen Therapeutics

15:35 - 16:15

Panel Discussion
Gene and Cell Therapy - How to Translate Technology Innovation to Industrialization and Commercialization

Moderator:Simone Fishburn, Ph.D., VP and Editor in Chief, BioCentury
Panelist:
Guangping Gao, Ph.D., President of American Society of Gene & Cell Therapy, Professor of University of Massachusetts Medical School
John Dawson, CEO, Oxford Biomedica
Frederic Revah, Ph.D., CEO, Genethon
Brian Min, Ph.D., CEO, GenScript Biotech Biological Drug Business Unit
Richard Wang, Ph.D., CEO, Fosun Kite
James Li, CEO and Co-founder, JW Therapeutics

16:15 - 16:55

Panel Discussion
From Scale to Value - Capital Potential of China's Cell Therapy Industry

Moderator: James Huang, Founding Partner of Panacea Venture , Managing Partner of KPCB China
Panelist:
Brad Loncar, Founder &CEO , Loncar Investment
Robin Meng, Executive Director, GenScript Biotech
Hongbo Lu, Ph.D., Managing Partner, Lilly Asia Ventures
Bin Li, Ph.D., Founder and Chief Investment Officer, Lake Bleu Capital
Mark Tang,Managing Director, Founding Partner , Good Health Capital
Ling Zhang, Head of Healthcare and Technology Investment, JPMorgan

16:55 - 17:35

Panel Discussion
Global Cell Therapy Regulatory Dialogue

Moderator: Becky Wood, Head of Sidley's Food, Drug and Medical Device Regulatory Practice, Former Chief Counsel of FDA
Panelist:
Alex Xu, M.D., Ph.D., Chief Scientist, CFDA/CDE
Ke Liu, MD, Ph.D., Associate Director for Cell and Gene Therapy, Oncology Center of Excellence & Chief of Oncology Branch, FDA
Li Zhu, Ph.D., Chief Strategy Officer, GenScript Biotech
Gang Wang, Ph.D., Chief Quality Officer and Senior Vice President, Shanghai Junshi Biosciences

17:35 - 17:55

Development Opportunities of Car-T in Nanjing

Xiumei Miao, Deputy District Mayor, Nanjing Jiangning Government

17:55 - 18:00

Closing Remarks

Sally Wang, co-founder, Executive Director and President, GenScript Biotech

18:00 - 20:00

Reception

Registration

  1. Pre-registration: 50 yabo体育yabo体育首页D /Person
  2. On-site Registration: 300 yabo体育yabo体育首页D /Person (January 14, 2020)
  3. Contact us at event@genscript.com / +86 025-58895776-6321

Photo Gallery

Confirmed Speakers

yabo体育首页Usman Azam, M.D.

CEO, Tmunity Therapeutics

Laurence Cooper, M.D., Ph.D.

CEO, Ziopharm Oncology

yabo体育首页John Dawson

yabo体育首页CEO, Oxford Biomedica

yabo体育首页Peter Emtage, Ph.D.

Global Head of Cell Therapy Research,
yabo体育首页 Kite Pharma, a Gilead Company

yabo体育首页Frank Fan, M.D., Ph.D.

CSO, Legend Biotech

yabo体育首页Simone Fishburn, Ph.D.

Vice President and Editor in Chief, BioCentury

yabo体育首页Guangping Gao, Ph.D.

President of American Society of
Gene and Cell Therapy,
Professor of University of
yabo体育首页 Massachusetts Medical School

Scott Gottlieb, M.D.

Former FDA Commissioner

yabo体育首页James Huang

Founding Partner of Panacea Venture,
Managing Partner of KPCB

Bin Li, Ph.D.

Founder and Chief Investment Officer,
Lake Bleu Capital

yabo体育首页Ke Liu, M.D., Ph.D.

Associate Director for Cell and
Gene Therapy, Oncology Center of
Excellence & Chief of Oncology Branch, FDA

James Li

CEO and Co-founder,
JW Therapeutics

Zonghai Li, M.D., Ph.D.

yabo体育首页Executive Chairman, CEO&CSO and Founder, CARsgen Therapeutics

yabo体育首页Brad Loncar

Founder &CEO, Loncar Investment

yabo体育首页Hongbo Lu, Ph.D.

Managing Partner, Lilly Asia Ventures

Robin Meng

Executive Director,
yabo体育首页 GenScript Biotech Corporation

Xiumei Miao

Deputy District Mayor,
Nanjing Jiangning Government

Brian Min, Ph.D.

yabo体育首页CEO, GenScript Biotech Biological Drug Business Unit.

Frédéric Revah Ph.D.

CEO, Généthon

yabo体育首页Mark Tang,Ph.D.

Managing Director, Founding Partner, Good Health Capital New York

Phil Vanek, Ph.D.

GM of Cell and Gene Therapy Strategy and Business Development, GE Healthcare Life Sciences

yabo体育首页Dan Wang, M.D.

yabo体育首页Head, Johnson & Johnson Innovation Asia Pacific

yabo体育首页Gang Wang, Ph.D.

yabo体育首页Chief Quality Officer and Senior Vice President, Shanghai Junshi Biosciences

Richard Wang, Ph.D.

CEO, Fosun Kite Biotechnology

Sally Wang

Co-founder, Executive Director, President, GenScript Biotech Corporation

Becky Wood

Head of Sidley's Food, Drug and Medical Device Regulatory Practice, Former Chief Counsel of FDA

Alex Xu, M.D., Ph.D.

Chief Scientist, CFDA/CDE

yabo体育首页Frank Zhang, Ph.D.

yabo体育首页Founder, Chairman and CEO,GenScript Biotech Corporation

Ling Zhang

yabo体育首页Managing Director, Head of China Healthcare Investment Banking, J.P. Morgan

yabo体育首页Li Zhu, Ph.D.

Chief Strategy Officer,
GenScript Biotech Corporation

更多参会嘉宾»

许远

传奇生物CEO

Lynn J. Rothschild

NASA Ames Research Center

Nathan Hillson

Joint BioEnergy Institute

Rhiju Das

Stanford University

许远

传奇生物CEO

yabo体育首页Lynn J. Rothschild

NASA Ames Research Center

yabo体育首页Nathan Hillson

Joint BioEnergy Institute

Rhiju Das

Stanford University

Strategic Partners

Cooperation Partners

    

Media

Attendee List

Genentech
Boehringer Ingelheim
Roche
AbbVie
Lonza
Bayer
GenEdit, Inc.
Thermo Fisher Scientific
Yale University
Stanford University
University of Pennsylvania
Cornell University
University of California, Berkeley
iDNA, Inc
J.P. Morgan
Jones Day
Lilly Asia Ventures
Loncar Investments
Sangamo therapeutics
Innovation America LLC
Cisen Pharmaceutical Co., Ltd.
GenoImmune Therapeutics
IQVIA
Danaher Corporation
Poseida Therapeutics
JOINN Biologics
BioProgress Technology Ltd
Maravai Life Sciences
Unleash Immuno Oncolytics
Simcere of America
Calidi Biotherapeutics
ImmunoBiochem
Lumira Ventures
Fox Rothschild LLP
Accelerated Technologies
Almirall, S.A.
Alphamab Oncology
MedTech International Group
GenSight Biologics
Hyun & Partners Korea
Navaux, Inc
Quintara Discovery
Lake Capital Investment
Leadart Technologies
MedAbome, Inc.
Sciclone Pharmaceuticals
Good Health Capital New York
ReInno Capital
6 Dimensions Capital
Panacea Venture
Morrison & Foerster LLP
Qiming Venture Partners

Venue

Grand Hyatt San Francisco

GenScript Biotech Global Forum